Document is current
Any future updates will be listed below
-
Authors
Mannowetz, Nadja
Chung, Sanny S. W.
Maitra, Soma
Noman, Md Abdullah Al
Wong, Henry L.
Cheryala, Narsihmulu https://orcid.org/0000-0003-1983-8236
Bakshi, Akash
Wolgemuth, Debra J.
Georg, Gunda I. https://orcid.org/0000-0002-8900-9460
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN275201300017C, 5P50HD093540, 5P50HD093540)
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 27 January 2025
First Online: 13 March 2025
Competing interests
: N.M. is co-founder and CSO of YourChoice Therapeutics; A.B. is co-founder and CEO of YourChoice Therapeutics; The Regents of the University of Minnesota hold a patent related to this work (Publication No.US-2022-0388993-A 1, Publication Date: 12/08/2022); G.I.G. and N.C. are listed as inventors; YourChoice Therapeutics holds the exclusive license for the IP owned by the University of Minnesota; G.I.G. is a consultant with YourChoice Therapeutics.
